Michael Grunkin, Ph.D.
Chief Executive Officer Dr. Michael Grunkin is founder and managing director of Visiopharm. He received his Ph.D in image analysis from the Technical University of Denmark in 1993.
His post-doctoral work was carried out on Massachusetts Institute of Technology and Harvard Medical School, where he combined a strong theoretical and practical background in image analysis with applications from the life-sciences.
From 1996, he was the technical founder of two Danish companies developing advanced image analysis technology for diagnosing osteoporosis and various diseases manifesting themselves on the human retina. In 2001, he co-founded Visiopharm, which is focused on the development of general as well as application-specific image analysis solutions for the life-sciences.
Johan Doré Hansen, M. Sc.
Chief Technical Officer Johan Doré Hansen is co-founder and CTO in Visiopharm. He received his Master's Degree in image analysis from the Technical University of Denmark in 1995.
Until 1999, he developed high-speed industrial inspection systems though his own company, Imaging.
One of his major achievements is a hardwood parquet sorting system, which is currently running on several production lines. In 1999, he entered the field of life-science image analysis, and was the driving force behind the development of algorithms for diagnosing diseases manifesting themselves on the human retina. In 2001, he co-founded Visiopharm.
Senior Vice President, Operations, Americas Amanda Lowe is a Senior Vice President of Operations for Visiopharm, leading the US based team and all operations within the America's. She received her BA from Michigan State University and the Eli Broad School of Business in 1999, and became Six Sigma Green Belt, Lean, and Black Belt certified for healthcare through Villanova University in 2011.
In 2004 Ms. Lowe began her career in digital pathology as the National Sales Manager for Bacus Laboratories, Inc one of the first digital pathology companies on the market. Bacus Laboratories was acquired by Olympus America, Inc in 2006 and Amanda continued her digital pathology career with Olympus. In 2009, Amanda founded Digital Pathology Consultants; a consultancy firm who advised commercial digital pathology companies and digital pathology end users within the healthcare, research, and biopharmaceutical markets. Digital Pathology Consultants was acquired by Visiopharm in December 2012. At Visiopharm, Amanda has also held roles as a Director of Business Development and a Director of Marketing.
Chief Scientific Officer Andreas Schønau is the CSO of Visiopharm. He received his M.Sc. in Engineering from the Technical University of Denmark in 1997, and has since added diploma degrees in Business Administration and Management (EBA, 2002) and Information Technology (ITD, 2011) from the Engineering College of Copenhagen. Andreas has a solid background in technology and product development for the diagnostic and medical device industry.
He has been responsible for product development for Molecular Pathology with Danish based cancer diagnostic legacy Dako now Agilent technologies, including co-development projects with some of the world's largest pharmaceutical companies, and has brought several IVD class III products through FDA approval.
Andreas is a strategic and innovative thinker within the fields of diagnostics, personalized medicine and automation.
Chief Marketing Officer Helle Fisker is the CMO of Visiopharm. She received her M.Sc. in Biotech Engineering from the Technical University of Denmark in 1997.
During her carrier Helle has built a strong international experience in the areas of medical and pathology diagnostic marketing and sales. Staring out her professional career within Sales & Marketing being trained in pharmaceutical companies Eli Lilly and Glaxo Smith Kline, where she worked as a Product Manager for a wide range of products mainly within oncology and vaccines.
Later Helle held several positions within Global Product Marketing with Danish based cancer diagnostic legacy Dako now Agilent technologies ending up being head of Pathology Reagent Product Marketing. Due to her achievements in pathology marketing Helle became head of European marketing for the core histology division at Leica Microsystems and later on VP Sales & Marketing for a Danish founded Biomarker Company.
Kristian Dalhof Nielsen
Chief Financial Officer Kristian Dalhof Nielsen is the CFO in Visiopharm. He received his M.Sc. Economics and Business Administration from the Copenhagen Business School in 2003.
Kristian’s main focus has always been to secure data quality and business support, as well as creating transparency and objectivity in his positions.
Kristian has proven instrumental in doing this in different industries such as Fuel, Market analysis, IT and Insulation. Prior to joining Visiopharm, Kristian worked for Rockwool Scandinavia.
Torbjørn Kristensen, M. Sc.
Vice President of Professional Services Torbjørn Kristensen is the Vice President of Professional Services. He received his Master’s Degree in Medicine and Technology in 2009 from Technical University of Denmark same year that he joined Visiopharm.
Since his start at Visiopharm his focus has been to improve and professionalize training, service and support for a fast growing Visiopharm customer base.
Torbjørn has grown the overall team capabilities and is today managing the Professional Services department, which supports a worldwide customer base.